We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan, Wyeth Settle Dispute Over Generic Effexor
Mylan, Wyeth Settle Dispute Over Generic Effexor
December 8, 2009
Wyeth has granted Mylan Pharmaceuticals a nonexclusive license to patents relating to its antidepressant, ending patent litigation initiated after Mylan
filed an ANDA for generic Effexor extended-release (ER) capsules in 37.5-, 75- and 150-mg strengths.